0001193125-21-200329.txt : 20210625 0001193125-21-200329.hdr.sgml : 20210625 20210625160154 ACCESSION NUMBER: 0001193125-21-200329 CONFORMED SUBMISSION TYPE: 6-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210625 FILED AS OF DATE: 20210625 DATE AS OF CHANGE: 20210625 FILER: COMPANY DATA: COMPANY CONFORMED NAME: NuCana plc CENTRAL INDEX KEY: 0001709626 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 6-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38215 FILM NUMBER: 211047654 BUSINESS ADDRESS: STREET 1: 3 LOCHSIDE WAY CITY: EDINBURGH STATE: X0 ZIP: EH12 9DT BUSINESS PHONE: 44-0-131-357-1111 MAIL ADDRESS: STREET 1: 3 LOCHSIDE WAY CITY: EDINBURGH STATE: X0 ZIP: EH12 9DT FORMER COMPANY: FORMER CONFORMED NAME: NuCana BioMed Ltd DATE OF NAME CHANGE: 20170619 6-K 1 d157218d6k.htm 6-K 6-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

OF THE SECURITIES EXCHANGE ACT OF 1934

For the month of June 2021

(Commission File No. 001-38215)

 

 

NUCANA PLC

(Translation of registrant’s name into English)

 

 

3 Lochside Way

Edinburgh EH12 9DT

United Kingdom

(Address of registrant’s principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F  ☒             Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101 (b) (7):  ☐

 

 

 

Other Events

On June 24, 2021, NuCana plc (the “Company”) held its Annual General Meeting (the “AGM”) at Lochside House, 3 Lochside Way, Edinburgh, EH12 9DT, United Kingdom. All of the resolutions set out in the Company’s notice of the AGM dated May 20, 2021 and furnished on Form 6-K with the Securities and Exchange Commission on May 24, 2021 were duly proposed and passed.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

NuCana plc
By:  

/s/ Donald Munoz

  Name:   Donald Munoz
  Title:   Chief Financial Officer

Date: June 25, 2021